Enhanced Nitrite-Mediated Relaxation of Placental Blood Vessels Exposed to Hypoxia Is Preserved in Pregnancies Complicated by Fetal Growth Restriction
Open Access
- 26 April 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4500
Abstract
Nitric oxide (NO) is essential in the control of fetoplacental vascular tone, maintaining a high flow−low resistance circulation that favors oxygen and nutrient delivery to the fetus. Reduced fetoplacental blood flow is associated with pregnancy complications and is one of the major causes of fetal growth restriction (FGR). The reduction of dietary nitrate to nitrite and subsequently NO may provide an alternative source of NO in vivo. We have previously shown that nitrite induces vasorelaxation in placental blood vessels from normal pregnancies, and that this effect is enhanced under conditions of hypoxia. Herein, we aimed to determine whether nitrite could also act as a vasodilator in FGR. Using wire myography, vasorelaxant effects of nitrite were assessed on pre-constricted chorionic plate arteries (CPAs) and veins (CPVs) from normal and FGR pregnancies under normoxic and hypoxic conditions. Responses to the NO donor, sodium nitroprusside (SNP), were assessed in parallel. Nitrate and nitrite concentrations were measured in fetal plasma. Hypoxia significantly enhanced vasorelaxation to nitrite in FGR CPAs (p < 0.001), and in both normal (p < 0.001) and FGR (p < 0.01) CPVs. Vasorelaxation to SNP was also potentiated by hypoxia in both normal (p < 0.0001) and FGR (p < 0.01) CPVs. However, compared to vessels from normal pregnancies, CPVs from FGR pregnancies showed significantly lower reactivity to SNP (p < 0.01). Fetal plasma concentrations of nitrate and nitrite were not different between normal and FGR pregnancies. Together, these data show that nitrite-mediated vasorelaxation is preserved in FGR, suggesting that interventions targeting this pathway have the potential to improve fetoplacental blood flow in FGR pregnancies.Keywords
Funding Information
- British Heart Foundation (FS/15/31/31418)
This publication has 31 references indexed in Scilit:
- Pathophysiology of placental-derived fetal growth restrictionAmerican Journal of Obstetrics and Gynecology, 2018
- Impact of cerebral redistribution on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: a systematic reviewUltrasound in Obstetrics & Gynecology, 2015
- Maternal and fetal risk factors for stillbirth: population based studyBMJ, 2013
- Diagnosis and Management of Fetal Growth RestrictionJournal of Pregnancy, 2011
- Early life programming of obesity and metabolic diseasePhysiology & Behavior, 2008
- Histomorphology of the Placenta and the Placental Bed of Growth Restricted Foetuses and Correlation with the Doppler Velocimetries of the Uterine and Umbilical ArteriesPlacenta, 2003
- Birth Weight in Relation to Morbidity and Mortality among Newborn InfantsNew England Journal of Medicine, 1999
- Control of vascular resistance in the maternal and feto-placental arterial bedsPharmacology & Therapeutics, 1995
- Fetal and placental size and risk of hypertension in adult life: Authors' replyBMJ, 1990
- Lack of innervation of human umbilical cord. An immunohistological and histochemical studyPlacenta, 1990